Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-26

Clinical Trial Update: Trial of Aspirin and Arginine Restriction in Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating aspirin and arginine restriction in colorectal cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Arginine restriction
  • Aspirin (Aspirin)

Snippet

Sponsor: University of California, Irvine | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-06-26